Among the variables, patients with higher expression of GFAT1 significantly tended to be diagnosed at advanced pTNM stage (P = 0.033) and have higher rates of lymph node metastasis (P = 0.020). This evidence concerns the gene GFPT1 and metastatic malignant neoplasm in the lymph nodes.